Merck Provides Update on Phase 3 KEYNOTE-B21 Trial Evaluating KEYTRUDA®[...]
Quarterly Report for Quarter Ending March 31, 2024 (Form 10-Q)
04/26/2024 | Press release | Distributed by Public on 04/27/2024 04:37
Mise à disposition du Document d'Enregistrement Universel 2023
Please select the service you want to use:
Smartlinks | Micropole SA | News | Education | Securities Issuers | IT Service Companies | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Berlin Stock Exchange | Munich Stock Exchange | Euronext Paris | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | SIGMA X MTF | Euronext Block MTF | Turquoise
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact